JOIN US IN PERSON OR VIRTUALLY!

Overview

Immerse yourself in groundbreaking advancements in adoptive immunotherapy that are revolutionizing the treatment landscape for hematologic malignancies and beyond. Join us as we convene esteemed national experts in a forum for collaboration and scientific discourse. Together, we'll delve into basic science and translational research, unlocking the potential of cellular therapeutics for hematologic malignancies, solid tumors, and non-oncologic conditions. This symposium isn't just about dialogue—it's about shaping the future of medicine. Be part of a transformative journey that transcends boundaries, fosters interdisciplinary partnerships, and propels us closer to the ultimate goal: enhancing patient lives through the power of cellular therapy.

Learning Objectives

After this activity, participants will be able to:

• Recall current applications of CAR T-cell therapy in hematologic malignancies;
• Identify relevant targets and new therapeutic approaches for cellular therapy in solid tumor malignancies;
• Define the concept of epitope editing and how it may facilitate the broader application of cellular therapy treatments;
• State current advances in cellular therapy engineering including in vivo transduction and through the use of nanoparticles;
• Describe current approaches and challenges using cellular therapy in patients with solid tumor malignancies;
• List some of the mechanisms of relapse and resistance to cellular therapy;
• Discuss current strategies using cellular therapy for the treatment of viral infections and associated conditions;
• Evaluate strategies to overcome resistance to cellular therapy treatment approaches;
• Assess the clinical applicability of new therapeutic strategies in cellular therapy research.

Target Audience

This activity is designed for basic and translational researchers, hematology and medical oncology physicians and fellows, immunologists, and other healthcare professionals interested in tumor immunology and cellular immunotherapy.

Accreditation

Physician Credit

The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 7 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Participant Credit

Other participants will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.

For more information please visit the official event page.